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Four peptides derived from rat brain protein kinase C were partially sequenced. Using synthetic oligonu- 
cleotides deduced from the amino acid sequences as probes, a clone of complementary DNA (cDNA) was 
isolated from a cDNA library prepared from the same tissue. The nucleotide sequence of this cDNA clone 
revealed the primary structure of the carboxyl-terminal region as having 224 amino acids, with significant 
sequence homology with cyclic AMP-dependent and cyclic GMP-dependent protein kinases. 
Protein kinase C Lysylendopeptidase 
1. INTRODUCTION 
Protein kinase C consists of a single polypeptide 
chain with an M, of approx. 77000 [ 11. This en- 
zyme appears to play a crucial role in signal 
transduction for a variety of biologically active 
substances which activate cellular functions and 
proliferation [2,3]. Since the protein kinase C has 
been generally regarded as the receptor for 
tumour-promoting phorbol esters, elucidation of 
the structure of this enzyme may obviously provide 
clues for understanding the molecular mechanism 
of cell growth and differentiation. Here we wish to 
describe cloning of cDNA and its nucleotide se- 
quence, that encodes the carboxyl-terminal region 
of rat brain protein kinase C. 
2. MATERIALS AND METHODS 
2.1. Preparation of the peptide fragments with 
lysylendopeptidase 
Rat brain protein kinase C was purified by the 
procedure described in [4], and the enzyme 
employed for the present studies was practically 
Abbreviation: HPLC, high-performance liquid 
chromatography 
complementary DNA Nucleotide sequence 
pure as judged by silver staining after SDS- 
polyacrylamide gel electrophoresis. The purified 
enzyme (1.9 mg protein) was digested with lysylen- 
dopeptidase (47.5 /cg) for 21 h at 37°C in 1.9 ml of 
50 mM Tris-HCl (pH 9.0) containing 6 M urea. 
The resultant peptide mixture was separated by 
preparative reverse-phase HPLC equipped with a 
Micropak protein C18-10 column (0.4 x 30 cm, 
Varian associates) at a flow rate of 1.3 ml/min as 
described in [5]. 
2.2. Amino acid sequencing 
Automated Edman degradation was carried out 
with a gas-phase protein sequencer, model 470A 
(Applied Biosystems). Phenylthiohydantoin 
derivatives of amino acids were determined by 
HPLC equipped with a Micropak SP C18-3 col- 
umn (Varian Associates). 
2.3. Construction of cDNA library from rat brain 
Poly(A) RNA was isolated from rat brain by the 
guanidine isothiocyanate-CsCl procedure [6], 
poiy(A) RNA 
followed by oligo(dT)-cellulose column chroma- 
tography [7]. The cDNA library was constructed 
by using the pcDV1 vector-primer and pL1 linker 
fragment according to Okayama and Berg [8,9]. 
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Amino acid sequences of the four major peptides selected 
Peptide no. Sequences Probe no. 
5 10 
24 Glu-His-Ala-Phe-Phe-Arg-Tvr-Ile-Asp-Trp- 1 
Glu-Lvs 
5 10 
37 Ile-His-Thr-Tyr-Gly- X -Pro-Thr-Phe- X - 
15 
Asp-His- X -Gly-Gly- 
5 10 
49 Ser-Val-Asp-Trp-Trp-Ala-Tyr-Gly-Val-Leu- 
15 20 
Leu-Tyr-Glu-Met-Leu-Ala-Gly-Gln-Pro-Pro- 
5 10 
51 Ser-Val-Asp-Trn-Trp-Ala-Phe-Glv-Val-Leu- 2 
15 20 
Leu-Tyr-Glu-Met-Leu-Ala-Gly-Gln-Ala-Pro- 
25 30 
Phe-Glu-Gly-Glu-Asr-Glu-Asp-GIu-Leu-Phe- 3 
Gln- 
The hexapeptide regions underlined were employed for preparing the 
oligonucleotides to be used as probes. X, unidentified amino acid 
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The cyclized vector-cDNA preparation was used to 
transform competent E. COED’ DHI cells. About 
5 pg poly(A) RNA yielded about 5 x lo5 indepen- 
dent transformants. 
TERS July 1986 
dried and autoradiographed with intensifying 
screens. 
2.5. Nucleo tide sequencing 
2.4. Screening of rat protein kinase C cDNA 
CoIony screening was performed by the high- 
density colony hybridization method [IO]. The 
probes were labelled by phosphorylation with 
[Y-~~P]ATP and Tb polynucleotide kinase. Two 
rephca nitrocellulose filters were prepared from 
the master filters, and each was probed with the 
radioactive synthetic oligonucleotides (probe no.2 
or probe no.3 in fig.1). Hybridization was carried 
out for 16 h at 42°C in a solution containing 5 x 
SSPE [ll], 5 x Denhardt’s solution [ll], 
100 pg/ml sonicated heat-denatured salmon sperm 
DNA, 0.1% SDS, and the probes. After hybridiza- 
tion, the filters were washed by immersing them 
twice each time with a sufficient volume of 6 x 
SSC [1 1] containing 0.1% SDS at room 
temperature for 60 min, and further twice with the 
same solution at 47°C (for probe no.2) or at 43°C 
(for probe no.3) for 60 min. The filters were then 
Nucleotide sequence analysis was carried out by 
subcloning suitable restriction endonuclease 
fragments into Ml3-based cloning vectors 
(Ml3mplO and Ml3mpll) followed by primed 
DNA synthesis on single-stranded DNA tempIates 
in the presence of dideoxynucleoside triphos- 
phates. 
3. RESULTS 
3.1. Partial amino acid sequence of protein 
Treatment of protein kinase C with lysylen- 
dopeptidase resulted in the formation of approx. 
50 peptides, which were fractionated by 
preparative reverse-phase HPLC. Four major pep- 
tides (nos 24, 37, 49 and 51) were selected, and 
their amino acid sequences were partially deter- 
mined. The results are summarized in table 1. For 
screening of cDNA clones that contain the protein 
Table 1 
kinase C 
112 
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kinase C sequence, three batches of mixed determined by the chain termination method. 
oligonucleotides, each 17 nucleotides long, were Restriction endonuclease cleavage map and the 
prepared as probes, which are shown in fig. 1. The strategy of nucleotide sequence determination are 
first, probe no.1 (24 mixtures), encoded amino summarized in fig.2a. Fig.Zb shows the partial 
acids 7-12 of the peptide no.24. The second, probe nucleotide sequence of the pCKR9 insert, together 
no.2 (16 mixtures), encoded amino acids 3-8 of with the amino acid sequence predicted therefrom. 
the peptide no.51. The third, probe no.3 (64 mix- The nucleotide sequences of residues 445-480 and 
tures), corresponded to the region of amino acids 220-312 corresponded exactly to the amino acid 
24-29 of the peptide no.51. sequences of peptides no.24 and no.51, respective- 
3.2. cDNA cloning of protein kinase C 
A cDNA library complementary to poly(A) 
RNA of rat brain was constructed by the pro- 
cedure of Okayama and Berg [8,9]. For the first 
screening of the cDNA library, a mixture of 
[32P]oligonucleotide probes (nos 2 and 3) was 
employed. Two replica filters were prepared from 
the master filters, and examined with each 
oligonucleotide probe. Out of 3 x 10’ colonies, on- 
ly one clone was obtained which obviously 
hybridized to both probes. When plasmid DNA 
from this clone, designated to pCKR9, was sub- 
jected to Southern blot analysis, the pCKR9 insert 
was hybridized not only to probes no.2 and no.3, 
but also to probe no.1. To confirm that pCKR9 
contained the protein kinase C sequence, the 
nucleotide sequence of the pCKR9 insert was 
a 
PstI Sau3A SphI PstI HindIIIEcoRI 
1 . t . 
. . 4 
. . - 
b 
- 
1OObp 
a) Tyr-Ile-Asp-Trp-Glu-Lys 
60 
20 
120 
40 
180 
60 
240 
SO 
300 
100 
360 
120 
420 
140 
480 
160 
540 
IS0 
600 
200 
660 
220 
720 
780 
040 
900 
960 
1020 
1080 
1140 
b) Asp-Trp-Trp-Ala-Phe-Gly 
S-CC$A~GCCCACCA+ 
C 
T 
cl Glu-Asp-Glu-Asp-Glu-Leu 
Fig. 1. Synthetic oligonucleotides employed for screening 
cDNA clones for rat brain protein kinase C. Mixed 
17-mer oligonucleotides are complementary to all 
possible coding sequences corresponding to the three 
hexapeptides hown in table 1. (a) Probe no. 1, residues 
7-12 of peptide no.24; (b) probe 110.2, residues 3-8 of 
peptide no.51; (c) probe no.3, residues 24-29 of peptide 
no.51. 
GTCATYAATGTGTAGGTGMTGCAGATI'CCATCGCTGAGCCTC 
VdIleAsnV.1 - 
TGAATGTCTAITATCAATPCCAGTCTPCCAGGATPCATGGTGCCTC~TYGGCATCCGTC 
ATGTGGAGAGCAGGGCTPTP~TA~TATA~CTAG~G~ 
TACA'FPycAAAA~AGTlTAGMTAAGTGCATl'GcCCAcTGATAGAGGTACAATrry 
CCAGACTTCCAGAAACTCATCCAATqAACCAACAGTGTCAAAACTTAAcTGTGTcCGATA 
CCAAMTOCTTCAOTA~T~~~~AGA~~A~~C~TC~G~ 
mACA~ACTCTCOUTATCTC~~~~ACCTUOCAT 
AAGTETCAGTAA GCTTPGCAGTTACTGT.3McT CTTGTCTCTTUGAGGAAACWTWGT 
ITUOM~TA~~~UITCATATA~CLA)n 
Fig.2. Nucleotide sequence and predicted amino acid 
sequence of the pCKR9 insert. (a) Restriction 
endonuclease cleavage map of pCKR9 and strategy for 
nucleotide sequence determination. Thin lines and bold 
lines indicate vector and oligo (dG-dC) (or dA-dT) tails, 
respectively. Closed and open boxes indicate coding and 
untranslated region, respectively. Horizontal arrows 
indicate regions and directions of sequencing. (b) 
Nucleotide sequence and predicted amino acid sequence 
of the pCKR9 insert. Numbering of nucleotides and 
amino acids is tentative. The poly(A) additional signal is 
underlined. 
113 
Volume 203, number 2 FEBS LETTERS July 1986 
ly. The amino acid composition of the predicted 
peptide of residues 74-l 14 was almost identical to 
that of peptide no.51 (not shown). A sequence of 
ATTAAA, an analogous sequence of the poly(A) 
additional signal AATAAA [ 121, was found 16 
nucleotides upstream of the poly(A) homopolymer 
stretch. 
From these results, it may be concluded that 
pCKR9 is the cDNA that encodes the carboxyl- 
terminal region of rat brain protein kinase C, and 
contains the complete 3 ’ -untranslated region. 
4. DISCUSSION 
Based on the results presented above, it is possi- 
ble to predict the sequence of the carboxyl- 
terminal 224 amino acid residues of protein kinase 
C. The cDNA clone thus obtained perhaps covers 
about one-third of the entire cDNA sequence, 
assuming that protein kinase C consists of 700-750 
amino acid residues. Fig.3 shows an alignment of 
the predicted carboxyl-terminal amino acids of rat 
brain protein kinase C with those of the catalytic 
subunit of bovine heart cyclic AMP-dependent 
protein kinase [13] and bovine lung cyclic GMP- 
dependent protein kinase [14]. A significant amino 
acid homology may be seen among these three 
protein kinases. This sequence conservation over 
different species seems to indicate that this region 
is one of the essential domains for the protein 
kinase activity. 
Comparing the amino acid sequence of peptide 
no.49 with that of peptide no.51, only two residues 
C-kinaoe 
A-kinaae 
G-kinase 
c-kinaae 
A-kinaae 
o-klnase 
C-kinare 
A-kinare 
G-kinare 
Fig.3. Comparison of the predicted carboxyl-terminal 
region of rat brain protein kinase C with other protein 
kinases. Hyphens have been introduced for optimal 
alignment. C-kinase, rat brain protein kinase C; A- 
kinase, catalytic subunit of bovine heart cyclic AMP- 
dependent protein kinase [13]; G-kinase, bovine lung 
cyclic GMP-dependent protein kinase [ 141. 
differ (table 1, residues 7 and 19), suggesting that 
the purified protein kinase C is a mixture of two 
closely related polypeptides, although the existence 
of repeat of the almost same sequences in a single 
polypeptide chain of protein kinase C may not be 
ruled out. As described earlier [4], the enzyme 
purified from rat brain frequently reveals a 
doublet upon SDS-polyacrylamide gel elec- 
trophoresis, and both protein bands are reactive 
with three different monoclonal antibodies against 
protein kinase C. It is most likely that there exist 
at least two types of the enzyme which may be 
derived from closely similar but distinctly different 
genes. In fact, several cDNA clones were isolated 
which could hybridize to the pCKR9 insert but 
showed restriction maps different from that of the 
pCKR9 insert (not shown). Further analysis of 
these cDNA clones will provide more information 
on the heterogeneity of protein kinase C. Recently, 
Uhler et al. [15] have cloned the cDNA encoding 
the catalytic subunit of cyclic AMP-dependent 
protein kinase, and noted some heterogeneity of 
the enzyme. The heterogeneity might be a common 
feature among protein kinases. 
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